205 related articles for article (PubMed ID: 34628681)
1. Gene Therapy for Polyglutamine Spinocerebellar Ataxias: Advances, Challenges, and Perspectives.
Vázquez-Mojena Y; León-Arcia K; González-Zaldivar Y; Rodríguez-Labrada R; Velázquez-Pérez L
Mov Disord; 2021 Dec; 36(12):2731-2744. PubMed ID: 34628681
[TBL] [Abstract][Full Text] [Related]
2. Polyglutamine spinocerebellar ataxias - from genes to potential treatments.
Paulson HL; Shakkottai VG; Clark HB; Orr HT
Nat Rev Neurosci; 2017 Oct; 18(10):613-626. PubMed ID: 28855740
[TBL] [Abstract][Full Text] [Related]
3. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Buijsen RAM; Toonen LJA; Gardiner SL; van Roon-Mom WMC
Neurotherapeutics; 2019 Apr; 16(2):263-286. PubMed ID: 30607747
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias.
Szpisjak L; Zadori D; Klivenyi P; Vecsei L
CNS Neurol Disord Drug Targets; 2019; 18(4):279-293. PubMed ID: 30864514
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.
Rüb U; Schöls L; Paulson H; Auburger G; Kermer P; Jen JC; Seidel K; Korf HW; Deller T
Prog Neurobiol; 2013 May; 104():38-66. PubMed ID: 23438480
[TBL] [Abstract][Full Text] [Related]
6. The wide spectrum of spinocerebellar ataxias (SCAs).
Manto MU
Cerebellum; 2005; 4(1):2-6. PubMed ID: 15895552
[TBL] [Abstract][Full Text] [Related]
7. Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias.
Afonso-Reis R; Afonso IT; Nóbrega C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921915
[TBL] [Abstract][Full Text] [Related]
8. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.
Coarelli G; Brice A; Durr A
F1000Res; 2018; 7():. PubMed ID: 30473770
[No Abstract] [Full Text] [Related]
10. Verification of Inter-laboratorial Genotyping Consistency in the Molecular Diagnosis of Polyglutamine Spinocerebellar Ataxias.
Ramos A; Raposo M; Milà M; Bettencourt C; Houlden H; Cisneros B; Magaña JJ; Bettencourt BF; Bruges-Armas J; Santos C; Lima M
J Mol Neurosci; 2016 Jan; 58(1):83-7. PubMed ID: 26454745
[TBL] [Abstract][Full Text] [Related]
11. MR Imaging in Spinocerebellar Ataxias: A Systematic Review.
Klaes A; Reckziegel E; Franca MC; Rezende TJ; Vedolin LM; Jardim LB; Saute JA
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1405-12. PubMed ID: 27173364
[TBL] [Abstract][Full Text] [Related]
12. Functional implications of paralog genes in polyglutamine spinocerebellar ataxias.
Felício D; du Mérac TR; Amorim A; Martins S
Hum Genet; 2023 Dec; 142(12):1651-1676. PubMed ID: 37845370
[TBL] [Abstract][Full Text] [Related]
13. Genes implicated in the pathogenesis of spinocerebellar ataxias.
Wüllner U
Drugs Today (Barc); 2003 Dec; 39(12):927-37. PubMed ID: 14747838
[TBL] [Abstract][Full Text] [Related]
14. Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion.
Niewiadomska-Cimicka A; Hache A; Trottier Y
Front Neurosci; 2020; 14():571. PubMed ID: 32581696
[TBL] [Abstract][Full Text] [Related]
15. Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies.
Underwood BR; Rubinsztein DC
Cerebellum; 2008; 7(2):215-21. PubMed ID: 18418676
[TBL] [Abstract][Full Text] [Related]
16. [The genetics of spinocerebellar ataxias].
Jacobi H; Minnerop M; Klockgether T
Nervenarzt; 2013 Feb; 84(2):137-42. PubMed ID: 23338152
[TBL] [Abstract][Full Text] [Related]
17. Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia.
Koutsis G; Pemble S; Sweeney MG; Paudel R; Wood NW; Panas M; Kladi A; Houlden H
J Neurol Sci; 2012 Jul; 318(1-2):178-80. PubMed ID: 22520093
[TBL] [Abstract][Full Text] [Related]
18. Polyglutamine spinocerebellar ataxias: emerging therapeutic targets.
Neves-Carvalho A; Duarte-Silva S; Teixeira-Castro A; Maciel P
Expert Opin Ther Targets; 2020 Nov; 24(11):1099-1119. PubMed ID: 32962458
[TBL] [Abstract][Full Text] [Related]
19. The clinical diagnosis of autosomal dominant spinocerebellar ataxias.
Klockgether T
Cerebellum; 2008; 7(2):101-5. PubMed ID: 18418679
[TBL] [Abstract][Full Text] [Related]
20. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group.
Pujana MA; Corral J; Gratacòs M; Combarros O; Berciano J; Genís D; Banchs I; Estivill X; Volpini V
Hum Genet; 1999 Jun; 104(6):516-22. PubMed ID: 10453742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
